Saracatinib Trial TO Prevent FOP

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

May 6, 2025

Study Completion Date

May 6, 2025

Conditions
Fibrodysplasia Ossificans Progressiva
Interventions
DRUG

AZD0530 Difumarate

AZD0530 for the duration of the trial

DRUG

Matching placebo

Matching placebo during 6 month RCT, AZD0530 thereafter

Trial Locations (3)

82467

RECRUITING

Klinikum Garmish-Partenkirchen, Garmisch-Partenkirchen

1081HV

RECRUITING

Amsterdam University Medical Center, Amsterdam

HA7 4LP

NOT_YET_RECRUITING

Royal National Orthopaedic Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Royal National Orthopaedic Hospital NHS Trust

OTHER

collaborator

Klinikum Garmisch-Patenkirchen

OTHER

collaborator

University of Oxford

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

AstraZeneca

INDUSTRY

collaborator

Innovative Medicines Initiative

OTHER

lead

Amsterdam UMC, location VUmc

OTHER